Skip to main content
. Author manuscript; available in PMC: 2021 Sep 23.
Published in final edited form as: ACS Appl Mater Interfaces. 2020 Sep 8;12(38):42499–42510. doi: 10.1021/acsami.0c10781

Figure 1.

Figure 1.

Schematic illustrations depicting (A) Synthesis of gardiquimod-loaded mesoporous silica coated polydopamine nanoparticles (gardi-mPDA) and NIR-assisted drug release. (B) Tumor ablation and drug release under NIR irradiation followed by activation of DCs and effector T cells in tumor draining lymph nodes for regression of primary and secondary tumors.